Recent Analyst Forecasts and Stock Ratings
Aardvark Therapeutics, Inc. Common Stock FAQ's
Aardvark Therapeutics, Inc. Common Stock has been rated by research analysts at RBC Capital, Stifel Nicolaus, Morgan Stanley in the past 90 days.
Aardvark Therapeutics, Inc. Common Stock has been rated by research analysts at RBC Capital, Stifel Nicolaus, Morgan Stanley in the past 90 days.